ASPCF - Acerus Pharmaceuticals GAAP EPS of -$0.01 revenue of $0.74M March, 15 2022 07:52 AM Acerus Pharmaceuticals Corp Acerus Pharmaceuticals press release (OTCQB:ASPCF): Q4 GAAP EPS of -$0.01. Revenue of $0.74M (+174.1% Y/Y). For further details see: Acerus Pharmaceuticals GAAP EPS of -$0.01, revenue of $0.74M